Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aspira Women's Health Inc.

0.1052
-0.0048-4.36%
Post-market: 0.10570.0005+0.48%19:15 EDT
Volume:820.07K
Turnover:85.00K
Market Cap:3.13M
PE:-0.09
High:0.1099
Open:0.1089
Low:0.0994
Close:0.1100
Loading ...

Aspira Women's Health CEO Resigns; Sandra Milligan Named Interim Chief Executive

MT Newswires Live
·
17 Dec 2024

Aspira CEO Nicole Sandford to depart, Sandra Milligan named interim

TIPRANKS
·
16 Dec 2024

Aspira Women’s Health Announces Appointment of DR. Sandra Milligan as Interim CEO

THOMSON REUTERS
·
16 Dec 2024

Aspira Women's Health Inc - Nicole Sandford to Depart as Aspira CEO

THOMSON REUTERS
·
16 Dec 2024

Press Release: Aspira Women's Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

Dow Jones
·
16 Dec 2024

Aspira Women’s completes first development milestone of ARPA-H award

TIPRANKS
·
03 Dec 2024

Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award

GlobeNewswire
·
03 Dec 2024

Aspira Womens Health Inc (AWH) Q3 2024 Earnings Call Highlights: Strategic Wins Amidst Market ...

GuruFocus.com
·
15 Nov 2024

Aspira Womens Health Q3 Sales $2.200M Miss $2.775M Estimate

Benzinga
·
14 Nov 2024

Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results

THOMSON REUTERS
·
14 Nov 2024

Aspira Women's Health Inc: Full Year 2024 Cash Guidance Reconfirmed as $13.0-$14.5 Mln

THOMSON REUTERS
·
14 Nov 2024

Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results

GlobeNewswire
·
14 Nov 2024

Aspira Women's Health Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
12 Nov 2024

Press Release: AWH ANNOUNCES Q3 2024 FINANCIAL RESULTS

Dow Jones
·
12 Nov 2024

Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration With Bioreference® to Include Ovawatch®

THOMSON REUTERS
·
07 Nov 2024

Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024

GlobeNewswire
·
04 Nov 2024